<--- Back to Details
First PageDocument Content
Cancer research / National Institutes of Health / War on Cancer / CaBIG / Breast cancer / Cancer / NCI-designated Cancer Center / Prostate cancer / American Association for Cancer Research / Medicine / Cancer organizations / Oncology
Date: 2008-02-25 14:16:20
Cancer research
National Institutes of Health
War on Cancer
CaBIG
Breast cancer
Cancer
NCI-designated Cancer Center
Prostate cancer
American Association for Cancer Research
Medicine
Cancer organizations
Oncology

Microsoft Word - PCP[removed]Summ final.doc

Add to Reading List

Source URL: deainfo.nci.nih.gov

Download Document from Source Website

File Size: 66,63 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

DocID: 1vl9e - View Document